Peroxisome Proliferator-Activated Receptor-γ Is a Target of Nonsteroidal Anti-Inflammatory Drugs Mediating Cyclooxygenase-Independent Inhibition of Lung Cancer Cell Growth-Reference-Cited by-同舟云学术

Peroxisome Proliferator-Activated Receptor-γ Is a Target of Nonsteroidal Anti-Inflammatory Drugs Mediating Cyclooxygenase-Independent Inhibition of Lung Cancer Cell Growth

Published:2002-11-01 Issue:5 Volume:62 Page:1207-1214
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Wick Marilee,Hurteau Greg,Dessev Christina,Chan Daniel,Geraci Mark W.,Winn Robert A.,Heasley Lynn E.,Nemenoff Raphael A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells

2. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer.;Chang;Cancer Res,2000

3. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.;Dannenberg;Semin Oncol,1999

4. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators and corepressors.;DiRenzo;Mol Cell Biol,1997

5. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth;Translational Oncology;2024-09

2. Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems;Current Oncology;2023-01-05

3. Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics;Frontiers in Pharmacology;2022-12-05

4. Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications;Ageing Research Reviews;2022-06

5. Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects;Pharmaceuticals;2022-05-18